On the treatment of vascular insufficiencies of the labyrinth with thymoxamine.
D000328:Adult; D000368:Aged; D007758:Ear, Inner / Q000098:blood supply*; D005260:Female; D006311:Hearing Disorders / Q000188:drug therapy*; D006320:Hearing Tests; D006801:Humans; D006973:Hypertension; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009333:Neck / Q000601:surgery; D011395:Promazine / Q000627:therapeutic use; D011413:Propantheline / Q000627:therapeutic use; D013562:Sympathectomy; D013565:Sympatholytics / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D013565:Sympatholytics; D014665:Vasodilator Agents; D011413:Propantheline; D011395:Promazine